ShiraTronics Announces Positive 12-Month Follow-Up Results from RELIEV-CM Pilot Study, Demonstrating Sustained Clinical Benefit with Investigational Implantable Neuromodulation Therapy for Chronic Migraine

Last Updated On September 17, 2025

Get Up to 20% OFF

News

Orthopedic surgeon says growing marathon culture in India is causing a surge in injuries: Here’s why

A moment that changed me: I cried about my cleft lip for the first time in my 60s

‘Wheeling through vineyards and chateaux country’: an ebike tour of France’s Loire valley

All the right moves! 17 personal trainers on the exercise they always recommend – from planks to face pulls

EE couldn’t change pricey broadband and TV deal after my husband died

We booked £4,000 in EasyJet flights – but it won’t let us postpone them all after devastating news

2025-09-16 – Press Releases – www.prnewswire.com

MINNEAPOLIS, Sept. 16, 2025 /PRNewswire/ — ShiraTronics, Inc., a clinical-stage medical device company focused on developing novel neuromodulation therapies for chronic migraine, today announced compelling 12-month follow-up data from its RELIEV-CM Pilot Study. The findings demonstrate…

Read the full article here.

Get Up to 20% OFF

Related Feeds

Experience: my daughters were born conjoined at the head

I’ve started full-time work and it’s non-stop – when do I get some time for me? | Ask Annalisa Barbieri

HKSH Fosters Collaboration for Innovation at Asia Summit on Global Health 2025, Through Partnership with United Imaging to Elevate Medical Imaging Excellence

Who needs quinoa? 17 overlooked and affordable superfoods, from peas and potatoes to popcorn and even sugar

Antengene Presents Results from Two Late-Stage Clinical Studies of Selinexor at ASH 2024

Final autopsy results on Gene Hackman and his wife, Betsy Arakawa, reveal complex health issues

Yoga to prevent stroke: 7 simple and effective poses that can help

SiPH Collaborates with IBM to Enhance Pathology Information System with Computational Advances and AI to Support Patients in Thailand and ASEAN

Landmark FDA Move: First Quality Control Protocol for Mesenchymal Stromal Cells (MSCs) Sets New Therapeutic Standard

Intrusive thoughts have convinced me I’m repulsive to look at | Ask Philippa

BPIPO and DCB Partner with LINK-J for the First Regenerative Medicine Investment Event in Tokyo

Siriraj × MIT Hacking Medicine 2025 Now Open for Applications Across Southeast Asia: A Call for Innovation to Tackle Greatest Healthcare Challenges

Nilesh Shah joins Illumina as Head of Region, AMEA

Dubai Humanitarian: Powerful New Documentary Reveals World’s Largest Humanitarian Logistics Hub

Long-term Commitment to Treating Endometriosis and Improving Women’s Quality of Life – Gedeon Richter at the World Congress on Endometriosis

LABCONNECT APPOINTS MITCHELL BLUMENFELD AS CHIEF FINANCIAL OFFICER

COMPANY

Mon-Fri 10 am to 7 pm.

Warehouse: (No Walk-In)

Scommerce, 1 Buroh Crescent #03-01
Cogent 1.Logistics Hub S(627545)

Qxpress, 30 Tuas West Rd, level 5, S (638386)

Wellness

Okonomiyaki Recipe (VEGAN) with homemade deliciouse sauce! Popular Japanese street food in 15mins!

Wellness

Do Probiotics Cause Gas? Truths and Myths About Probiotics

Wellness

30 MIN CARDIO HIIT Workout To Burn 500 Calories (Full Body, No Equipment, At Home)

Beauty

Why Your Body Needs Vitamin E: The Benefits of Vitamin E for Skin and Hair

Beauty

Should I See A Dermatologist?

Beauty

Summer Fun Without the Sun Damage—How Sunblock Sunscreen Keeps You Safe

All the content on this website, including medical opinion and any other health-related information, are solely to provide information only. Any information/statements on this blog are not intended to diagnose, treat, cure or prevent any disease, and should NOT be a substitute for health and medical advice that can be provided by your own physician/medical doctor. You should always consult a doctor before making any health or diet changes, especially any changes related to a specific diagnosis or condition.